Reports for PRO DOC LIMITEE
Company Name
PRO DOC LIMITEE
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 7 (2%) | |
| Resolved: | 329 (95%) | |
Discontinuation Reports |
149 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 144 (97%) | |
| Reversed: | 4 (3%) | |
Late reports |
16 (3%) |
|
Overdue reports |
6 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-02-20 | 2020-03-05 | 106777 |
| IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-14 | 2017-04-18 | 2304 |
| IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-05-09 | 2017-11-22 | 9705 |
| IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-03-04 | 2019-05-29 | 77376 |
| IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-06-29 | 2018-05-09 | 14365 |
| IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-07-12 | 2018-05-09 | 15521 |
| IRBESARTAN-HCTZ | 300MG 12.5MG | TABLET | Resolved | 2020-10-09 | 2020-10-30 | 126054 |
| IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-02-13 | 2019-04-25 | 75548 |
| IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-03-08 | 2019-04-17 | 78081 |
| IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-01-16 | 2019-03-05 | 72434 |
| LAMOTRIGINE-150 | 150MG | TABLET | Resolved | 2018-08-27 | 2018-08-31 | 59202 |
| LAMOTRIGINE-25 | 25MG | TABLET | Resolved | 2020-01-03 | 2020-02-01 | 102151 |
| LAMOTRIGINE-25 | 25MG | TABLET | Resolved | 2018-01-17 | 2018-08-29 | 36177 |
| LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-07-05 | 2017-10-19 | 14792 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2019-01-03 | 2019-01-22 | 70877 |
| LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-10-16 | 2020-11-23 | 126566 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2019-04-24 | 2019-06-14 | 82348 |
| LEVOFLOXACIN | 500MG | TABLET | Actual shortage | 2025-03-05 | 2025-04-21 | 251994 |
| LOPERAMIDE-2 | 2MG | TABLET | Resolved | 2018-09-11 | 2018-12-06 | 61249 |
| LOSARTAN | 50MG | TABLET | Resolved | 2017-10-06 | 2023-07-11 | 24761 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254240 |
| RIVASTIGMINE | 6MG | CAPSULE | To be discontinued | 2025-04-04 | 2025-04-04 | 254243 |
| TEMAZEPAM-15 | 15MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9551 |
| TEMAZEPAM-30 | 30MG | CAPSULE | Discontinued | 2017-05-08 | 2017-05-08 | 9554 |
| TERAZOSIN-2 | 2MG | TABLET | Discontinued | 2021-06-25 | 2021-08-12 | 141500 |
| TERAZOSIN-5 | 5MG | TABLET | Discontinued | 2021-06-25 | 2021-07-28 | 141503 |
| TRAMADOL-ACET | 37.5MG 325MG | TABLET | Discontinued | 2019-07-24 | 2019-09-12 | 89923 |
| ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2021-04-07 | 2021-04-08 | 137050 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-04-02 | 2021-04-03 | 136790 |